Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

New three-month data from a study of non-human primates underpins the biotech firm's decision to amend the small interfering RNA program.

Alphabet's Google is scrapping its goal to hire more employees from underrepresented groups and is reviewing some of its diversity, equity and inclusion (DEI) initiatives, joining a slew of US ...

Multiple sclerosis may lead to mild short-term memory loss that can affect your ability to recall information. Lifestyle changes could help you manage symptoms. Multiple sclerosis (MS) is a ...

Multiple sclerosis (MS) causes neurological symptoms that typically worsen over time. People with MS typically experience relapses, during which symptoms worsen or new symptoms appear. Depending ...